Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-001003
Filing Date
2017-01-04
Accepted
2017-01-04 16:41:54
Documents
2
Period of Report
2016-12-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5047
2 POA DOCUMENT poa.txt EX-24.4_692158 3577
  Complete submission text file 0001209191-17-001003.txt   10158
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 646-214-0700
ZIOPHARM ONCOLOGY INC (Issuer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HELICOS BIOSCIENCES CORPORATION 1 KENDALL SQUARE, BUILDING 700 CAMBRIDGE MA 02139
Business Address
Lafond Kevin G (Reporting) CIK: 0001429559 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33038 | Film No.: 17506235